Genomes in Orbit: Why space genomics needs bioethics now

Three problems with no earthly solution

The governance gap described above is not an abstract concern, but one that manifests in concrete, practical challenges that preliminary research by bioethicists has identified.[5] [6] Although not limited to these, three challenges stand as particularly pressing: the conditions under which consent can be meaningfully given and maintained; the protection of genomic data in an environment that strains conventional safeguards; and the risk that genetic information becomes a tool for selection and exclusion. Each of these problems exists in some form in terrestrial research, but spaceflight – including commercial spaceflight – intensifies them in ways that demand specific attention.

Consent in an environment where withdrawal is not simple

Informed consent rests on the assumption that research participation should be voluntary and that participants have the right to withdraw at any time. In the context of spaceflight, this assumption is strained to breaking point: a crew member cannot simply step off a spacecraft mid-flight. The power dynamics between a commercial operator and their clients and staff are also unlike those of a typical clinical trial, raising the concern that the pressure to participate may be subtle and structural rather than explicit.

Spaceflight missions are intense endeavours that demand constant attention, and in such an environment participants may find it difficult to get clear answers about what data is being collected, how it will be used, and what rights they can exercise during the mission. Ensuring that consent in these contexts is dynamic and ongoing is an essential safeguard.[7]

Data protection when the rules of the ground don't apply

Genomic data is one of the most sensitive categories of personal information that exists: it is uniquely identifying, and its implications extend beyond the individual to their family members. The space environment poses new security and access risks for genomic data governance, owing to operational constraints such as bandwidth limitations.[8] Institutional roles may also blur, with a single operator acting simultaneously as healthcare provider, research institution, and employer– a combination that would complicate accountability.

Initiatives to build secure genomic and multi-omics data banks have already emerged, covering both data collected on Earth[9] and in space.[10] But wide and thorough ethical deliberation will be needed to ensure these initiatives operate responsibly and adhere to the highest ethical standards in the field.

Discrimination and the risk of genomic gatekeeping

A further risk is that collected genomic data could be used as a selection mechanism. Although NASA has already taken steps to remove genetic data from its astronaut selection process,[11] private operators could come to favour crew members and travellers who possess genetic traits considered advantageous in space, such as high radiation resistance.[12] This scenario becomes especially plausible in the commercial context, where the standards of national agencies may not apply amid the competitive pressures of a fast-growing industry. The consequences could extend well beyond individual unfairness should genomic screening become normalised in eligibility procedures, since it risks intensifying existing social inequalities and setting a precedent with implications far beyond this particular sector.